TMEM201 overexpression is associated with tumor progression and unfavorable prognosis in hepatocellular carcinoma

Author:

Wang Xiaolei1,Fang Jun1,Wang An1,Zhu Wuhui1

Affiliation:

1. Qingdao Third People's Hospital

Abstract

Abstract Background More and more evidences suggest there was a relationship between nuclear envelope and tumor development, but the functional contributions of TMEM201 remain largely unidentified. Objective This study aimed to explore the TMEM201 mRNA expression and its potential biologic functions in hepatocellular carcinoma (HCC) patients. Methods Expression array and clinical data were collected from the Cancer Genome Atlas (TCGA) database. TMEM201 expression data and its clinical information in HCC were confirmed by Chi-square test and Student’s t test. We used Kaplan–Meier analysis, Cox regression and nomogram to evaluate the prognostic capability of TMEM201. Gene set enrichment analysis (GSEA) was applied to find significant biological pathways associated with TMEM201. Results In contrast to normal tissues, TMEM201 was remarkably upregulated in HCC (P < 0.05). High-expressing TMEM201 was significantly related to advanced TNM stage, poor histologic grade, high Ishak score, worse Child–Pugh grade, vascular invasion, positive alpha fetoprotein (AFP) (P < 0.05). Kaplan–Meier analysis revealed that high TMEM201 expression was associated with poor overall survival (OS) and disease-free interval (DFI). In addition, multivariate analysis confirmed that high-expressing TMEM201 was an independent predicter of unfavorable OS and DFI (P < 0.05). On the basis of TMEM201 and TNM stage, the nomograms had a good predictive performance. Furthermore, TMEM201 DNA copy gain and miR-500a-3p upregulation were related to high TMEM201 mRNA expression in TCGA-LIHC. GSEA analysis demonstrated that “cell cycle” pathway, “DNA replication” pathway, “spliceosome” pathway and “homologous recombination” pathway were significantly enriched. Conclusion Above mentioned results indicate that TMEM201 has potential as a novel therapeutic target in HCC, and it is a good predictor associated with progression and prognostics of HCC.

Publisher

Research Square Platform LLC

Reference26 articles.

1. Sung H, Ferlay J, Siegel RL et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 71(3), 209–249 (2021).

2. Hepatocellular carcinoma;Llovet JM;Nat Rev Dis Primers,2021

3. Survivin expression in hepatocellular carcinoma. Correlation with clinicopathological characteristics and overall survival;Kapiris I;J BUON,2019

4. Genomic instability and cancer: an introduction;Shen Z;J Mol Cell Biol,2011

5. Mitotic spindle assembly and gamma-tubulin localisation depend on the integral nuclear membrane protein Samp1;Larsson VJ;J Cell Sci,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3